BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) financials

BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]

Market Cap: ₹1,092Cr.
Current Price: ₹325
Stock P/E: 18.8
ROE: 8.26%
ROCE: 11.5%
Book Value: ₹166
Dividend Yield: 0.46%
52W High / Low: ₹489/272

In Sep 2026, BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) reported sales ₹176 Cr and net profit ₹14 Cr.

Annual TTM: sales ₹656 Cr, net profit ₹21 Cr.

Shareholding: Promoters 58.58% (Sep 2026), FIIs 2.09% (Sep 2026), DIIs 1.96% (Sep 2026), Public 37.36% (Sep 2026), No. of Shareholders 40,754% (Sep 2026).

BAJAJHCARE quarterly results (₹ Cr.)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	123	154	149	148	161	153	166	176
Expenses	101	143	124	121	131	130	137	145
Operating Profit	22	12	25	27	31	23	29	31
OPM %	18%	8%	16%	18%	19%	15%	17%	18%
Other Income	-1	13	1	0	1	-34	1	1
Interest	6	6	5	6	6	6	6	6
Depreciation	7	8	6	7	7	8	7	8
Profit before tax	8	11	14	15	19	-24	16	18
Tax %	-39%	1%	17%	24%	17%	-6%	16%	23%
Net Profit	12	11	12	11	16	-23	14	14
EPS in Rs	3.71	3.54	3.75	3.52	4.96	-6.79	4.07	4.19
Raw PDF	—	—	—	—	—	—	—	—

BAJAJHCARE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	410	657	680	646	473	543	611	656
Expenses	362	521	561	534	397	460	506	542
Operating Profit	48	136	119	112	76	83	105	113
OPM %	12%	21%	17%	17%	16%	15%	17%	17%
Other Income	7	7	1	-19	-105	16	-32	-31
Interest	7	8	13	18	30	28	22	24
Depreciation	12	16	18	17	28	28	28	29
Profit before tax	36	119	90	58	-86	43	23	29
Tax %	30%	30%	20%	25%	-3%	7%	33%	—
Net Profit	25	83	71	43	-84	40	16	21
EPS in Rs	9.14	30.11	25.87	15.59	-30.36	12.51	4.68	6.43
Dividend Payout %	0%	5%	6%	6%	-3%	8%	32%	—

BAJAJHCARE balance sheet (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
Equity Capital	14	14	14	14	14	16	17	17
Reserves	164	245	315	354	265	450	516	540
Borrowings	91	181	257	415	333	223	249	282
Other Liabilities	74	86	136	115	154	144	141	142
Total Liabilities	343	526	721	898	765	833	923	981
Fixed Assets	162	208	270	366	253	238	248	263
CWIP	5	57	52	22	7	3	8	11
Investments	5	0	0	0	0	0	0	0
Other Assets	170	260	399	510	506	591	667	708
Total Assets	343	526	721	898	765	833	923	981

BAJAJHCARE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	25	21	44	1	-22	92	22	58
Cash from Investing Activity	-13	-28	-109	-75	-93	-11	-15	-48
Cash from Financing Activity	-13	3	75	62	131	-97	-6	24
Net Cash Flow	-0	-4	10	-12	16	-16	0	35
Free Cash Flow	11	-2	-70	-74	-115	73	10	18
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	89%	62%	58%	9%	-10%	138%	32%	53%

BAJAJHCARE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	59.19%	59.19%	59.19%	59.19%	59.19%	58.29%	58.59%	58.58%
FIIs	1.01%	1.05%	1.09%	1.12%	1.18%	1.98%	2.19%	2.09%
DIIs	2.36%	2.52%	3.16%	2.99%	2.96%	2.91%	1.92%	1.96%
Public	37.45%	37.25%	36.56%	36.70%	36.67%	36.82%	37.30%	37.36%
No. of Shareholders	32,672	35,710	35,980	38,576	37,953	38,158	41,310	40,754

BAJAJHCARE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	77	88	55	99	110	139	169	140
Inventory Days	45	54	94	143	199	206	206	249
Days Payable	45	80	67	94	81	128	127	133
Cash Conversion Cycle	77	62	82	148	228	217	248	256
Working Capital Days	12	24	34	40	27	-0	141	132
ROCE %	16%	18%	36%	20%	14%	8%	11%	11%

BAJAJHCAREUpdated 22 Oct 2026, 21:24

Bajaj Healthcare Limited

BAJAJHCAREUpdated 22 Oct 2026, 21:24

Market Cap

₹1,092Cr.

Current Price

₹325

High / Low

₹489/272

Stock P/E

18.8

Book Value₹166

Dividend Yield0.46%

ROCE11.5%

ROE8.26%

Face Value₹5.00

About

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Sep 2023	101	8	82	-7	7	-3	4	-3	-1.25
Dec 2023	109	7	89	-7	7	-1	58	-2	-0.8
Mar 2024	134	6	118	-36	7	-33	-10	-30	-10.84
Jun 2024	132	8	108	0	7	9	23	7	2.58
Sep 2024	133	8	109	4	7	14	30	9	3
Dec 2024	123	6	101	-1	7	8	-39	12	3.71
Mar 2025	154	6	143	13	8	11	1	11	3.54
Jun 2025	149	5	124	1	6	14	17	12	3.75
Sep 2025	148	6	121	0	7	15	24	11	3.52
Dec 2025	161	6	131	1	7	19	17	16	4.96
Mar 2026	153	6	130	-34	8	-24	-6	-23	-6.79
Jun 2026	166	6	137	1	7	16	16	14	4.07
Sep 2026	176	6	145	1	8	18	23	14	4.19

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	218	8	189	0	9	12	37	8	2.78
Mar 2016	223	8	193	0	9	14	39	8	3.04
Mar 2017	231	8	200	2	11	14	43	8	2.83
Mar 2018	327	8	288	2	11	23	33	15	5.5
Mar 2019	370	8	327	1	11	24	33	16	5.91
Mar 2020	410	7	362	7	12	36	30	25	9.14
Mar 2021	657	8	521	7	16	119	30	83	30.11
Mar 2022	680	13	561	1	18	90	20	71	25.87
Mar 2023	646	18	534	-19	17	58	25	43	15.59
Mar 2024	473	30	397	-105	28	-86	-3	-84	-30.36
Mar 2025	543	28	460	16	28	43	7	40	12.51
Mar 2026	611	22	506	-32	28	23	33	16	4.68
TTM	656	24	542	-31	29	29	—	21	6.43

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	58.58%
FIIs	2.09%
DIIs	1.96%
Public	37.36%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	67.73%	0.74%	0.48%	31.06%
Mar 2024	67.74%	0.53%	0.43%	31.31%
Jun 2024	67.74%	0%	0%	32.27%
Sep 2024	59.19%	1.07%	1.97%	37.77%
Dec 2024	59.19%	1.01%	2.36%	37.45%
Mar 2025	59.19%	1.05%	2.52%	37.25%
Jun 2025	59.19%	1.09%	3.16%	36.56%
Sep 2025	59.19%	1.12%	2.99%	36.7%
Dec 2025	59.19%	1.18%	2.96%	36.67%
Mar 2026	58.29%	1.98%	2.91%	36.82%
Jun 2026	58.59%	2.19%	1.92%	37.3%
Sep 2026	58.58%	2.09%	1.96%	37.36%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	2	78	70	38	189	108	1	0	79	189
Mar 2016	7	82	81	39	209	130	1	0	78	209
Mar 2017	7	92	75	45	219	128	0	0	91	219
Mar 2018	7	107	87	68	268	127	2	0	140	268
Mar 2019	7	122	81	57	267	128	1	0	137	267
Mar 2020	14	164	91	74	343	162	5	5	170	343
Mar 2021	14	245	181	86	526	208	57	0	260	526
Mar 2022	14	315	257	136	721	270	52	0	399	721
Mar 2023	14	354	415	115	898	366	22	0	510	898
Mar 2024	14	265	333	154	765	253	7	0	506	765
Mar 2025	16	450	223	144	833	238	3	0	591	833
Mar 2026	17	516	249	141	923	248	8	0	667	923
Sep 2026	17	540	282	142	981	263	11	0	708	981

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	28	-17	-11	0
Mar 2016	25	-31	5	0
Mar 2017	22	-8	-13	0
Mar 2018	17	-12	2	7
Mar 2019	25	-13	-13	0
Mar 2020	21	-28	3	-4
Mar 2021	44	-109	75	10
Mar 2022	1	-75	62	-12
Mar 2023	-22	-93	131	16
Mar 2024	92	-11	-97	-16
Mar 2025	22	-15	-6	0
Mar 2026	58	-48	24	35

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	86	70	83	90	77	88	55	99	110	139	169	140
Inventory Days	50	56	45	57	45	54	94	143	199	206	206	249
Days Payable	63	46	51	74	45	80	67	94	81	128	127	133
Cash Conversion Cycle	73	80	78	73	77	62	82	148	228	217	248	256
Working Capital Days	-11	-17	-4	0	12	24	34	40	27	-0	141	132
ROCE %	16%	13%	13%	16%	16%	18%	36%	20%	14%	8%	11%	11%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of BAJAJ HEALTHCARE LIMITED (BAJAJHCARE)?

The reported market capitalisation for BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) is ₹1,092Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of BAJAJHCARE?

The current price shown for BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) on Fincrux is ₹325 with a 52-week high/low of ₹489/272.

What is the P/E ratio of BAJAJ HEALTHCARE LIMITED (BAJAJHCARE)?

The stock P/E for BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) is 18.8 on Fincrux, with ROE at 8.26% and ROCE at 11.5%.

What were BAJAJHCARE latest quarterly results?

For Sep 2026, BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) reported sales ₹176 Cr and net profit ₹14 Cr (figures in ₹ crore unless noted).

What are BAJAJHCARE annual sales and net profit?

For TTM, BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) shows sales of ₹656 Cr and net profit of ₹21 Cr on the Fincrux profit & loss statement.

Who owns BAJAJ HEALTHCARE LIMITED (BAJAJHCARE)?

Latest shareholding for BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) on Fincrux: Promoters 58.58% (Sep 2026), FIIs 2.09% (Sep 2026), DIIs 1.96% (Sep 2026), Public 37.36% (Sep 2026), No. of Shareholders 40,754% (Sep 2026).

Where can I find BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) financials?

BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show BAJAJHCARE balance sheet and cash flow?

Yes. The BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 22 October 2026 at 21:24